Is FOLFOXIRI alone or combined with targeted therapy administered as first-line treatment a reasonable choice for most patients with mCRC? Systematic review and network meta-analys...

por Zhou, Mingyi, Yu, Ping, Hernick Davin, Dengue Bilibili, Li, Yanrong, Wang, Yuanhe, Fu, Lingyu, Zhang, Jingdong
Publicado 2017